Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 50%Low 0 · 0%Moderate 1 · 50%High 0 · 0%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- Extended‐field chemoradiotherapy vs pelvic chemoradiotherapy · Acute adverse events
  Extended‐field radiotherapy for locally advanced cervical cancer 2018 · Cochrane Headline outcomes only
  RR 0.95 [0.2, 4.39]
  1 study · 74 participants
  Very low
Direct match · question page
- Extended‐field radiotherapy vs pelvic chemoradiotherapy · Acute adverse events
  Extended‐field radiotherapy for locally advanced cervical cancer 2018 · Cochrane Headline outcomes only
  RR 0.05 [0.02, 0.11]
  1 study · 388 participants
  Moderate

Extended‐field radiotherapy vs pelvic chemoradiotherapy

Acute adverse events

Extended‐field radiotherapy probably leads to lower acute adverse events compared with pelvic chemoradiotherapy (moderate certainty).

1 finding from 1 review

Extended‐field radiotherapy for locally advanced cervical cancer 2018 · Cochrane Headline outcomes only
RR 0.05 [0.02, 0.11]
1 study · 388 participants
Moderate

Extended‐field chemoradiotherapy vs pelvic chemoradiotherapy

Acute adverse events

It is very uncertain whether extended‐field chemoradiotherapy changes acute adverse events compared with pelvic chemoradiotherapy (very low certainty).

1 finding from 1 review

Extended‐field radiotherapy for locally advanced cervical cancer 2018 · Cochrane Headline outcomes only
RR 0.95 [0.2, 4.39]
1 study · 74 participants
Very low